Latest news
Entrada Therapeutics Releases Q2 2026 Financial Results - AlphaStreetAlphaStreet · Wed, 05 Aug 2026 18:34:56 GMTEntrada Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 13:38:55 GMTEntrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:00:09 GMTEntrada Therapeutics (NASDAQ: TRDA) details $82M H1 loss and $223M cash runway - Stock TitanStock Titan · Wed, 05 Aug 2026 11:11:50 GMTEntrada Therapeutics (Nasdaq: TRDA) reports Q2 2026 results and sets DMD, DM1 data timeline - Stock TitanStock Titan · Wed, 05 Aug 2026 11:04:58 GMTEntrada Therapeutics reports Q2 2026 results an... - PluangPluang · Wed, 05 Aug 2026 07:00:00 GMTEntrada Therapeutics publishes corporate presentation on genetic medicines pipeline for neuromuscular and inherited retinal diseases - BitgetBitget · Wed, 05 Aug 2026 04:19:51 GMTHow Calvin’s Entrada Scholars Program prepares students for college - calvin.educalvin.edu · Tue, 04 Aug 2026 13:51:21 GMT